-
Something wrong with this record ?
Botulinum Toxin Modulates Posterior Parietal Cortex Activation in Post-stroke Spasticity of the Upper Limb
T. Veverka, P. Hok, P. Otruba, J. Zapletalová, B. Kukolová, Z. Tüdös, A. Krobot, P. Kaňovský, P. Hluštík,
Language English Country Switzerland
Document type Journal Article
NLK
Directory of Open Access Journals
from 2010
Free Medical Journals
from 2010
PubMed Central
from 2010
Europe PubMed Central
from 2010
Open Access Digital Library
from 2010-01-01
Open Access Digital Library
from 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2010
- Publication type
- Journal Article MeSH
Post-stroke spasticity (PSS) is effectively treated with intramuscular botulinum toxin type A (BoNT-A), although the clinical improvement is likely mediated by changes at the central nervous system level. Using functional magnetic resonance imaging (fMRI) of the brain, this study aims to confirm and locate BoNT-A-related changes during motor imagery with the impaired hand in severe PSS. Temporary alterations in primary and secondary sensorimotor representation of the impaired upper limb were expected. Thirty chronic stroke patients with upper limb PSS undergoing comprehensive treatment including physiotherapy and indicated for BoNT treatment were investigated. A change in PSS of the upper limb was assessed with the modified Ashworth scale (MAS). fMRI and clinical assessments were performed before (W0) and 4 weeks (W4) and 11 weeks (W11) after BoNT-A application. fMRI data were acquired using 1.5-Tesla scanners during imagery of finger-thumb opposition sequences with the impaired hand. At the group level, we separately modeled (1) average activation at each time point with the MAS score and age at W0 as covariates; and (2) within-subject effect of BoNT-A and the effect of time since W0 as independent variables. Comprehensive treatment of PSS with BoNT-A significantly decreased PSS of the upper limb with a maximal effect at W4. Task-related fMRI prior to treatment (W0) showed extensive activation of bilateral frontoparietal sensorimotor cortical areas, bilateral cerebellum, and contralesional basal ganglia and thalamus. After BoNT-A application (W4), the activation extent decreased globally, mostly in the bilateral parietal cortices and cerebellum, but returned close to baseline at W11. The intra-subject contrast revealed a significant BoNT-A effect, manifesting as a transient decrease in the activation of the ipsilesional intraparietal sulcus and superior parietal lobule. We demonstrate that BoNT-A treatment of PSS of the upper limb is associated with transient changes in the ipsilesional posterior parietal cortex, possibly resulting from temporarily altered sensorimotor upper limb representations.
Department of Neurology Palacký University and University Hospital Olomouc Czechia
Department of Physiotherapy Palacký University and University Hospital Olomouc Czechia
Department of Radiology Palacký University and University Hospital Olomouc Czechia
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19028952
- 003
- CZ-PrNML
- 005
- 20190819103926.0
- 007
- ta
- 008
- 190813s2019 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fneur.2019.00495 $2 doi
- 035 __
- $a (PubMed)31143157
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Veverka, Tomáš $u Department of Neurology, Palacký University and University Hospital, Olomouc, Czechia.
- 245 10
- $a Botulinum Toxin Modulates Posterior Parietal Cortex Activation in Post-stroke Spasticity of the Upper Limb / $c T. Veverka, P. Hok, P. Otruba, J. Zapletalová, B. Kukolová, Z. Tüdös, A. Krobot, P. Kaňovský, P. Hluštík,
- 520 9_
- $a Post-stroke spasticity (PSS) is effectively treated with intramuscular botulinum toxin type A (BoNT-A), although the clinical improvement is likely mediated by changes at the central nervous system level. Using functional magnetic resonance imaging (fMRI) of the brain, this study aims to confirm and locate BoNT-A-related changes during motor imagery with the impaired hand in severe PSS. Temporary alterations in primary and secondary sensorimotor representation of the impaired upper limb were expected. Thirty chronic stroke patients with upper limb PSS undergoing comprehensive treatment including physiotherapy and indicated for BoNT treatment were investigated. A change in PSS of the upper limb was assessed with the modified Ashworth scale (MAS). fMRI and clinical assessments were performed before (W0) and 4 weeks (W4) and 11 weeks (W11) after BoNT-A application. fMRI data were acquired using 1.5-Tesla scanners during imagery of finger-thumb opposition sequences with the impaired hand. At the group level, we separately modeled (1) average activation at each time point with the MAS score and age at W0 as covariates; and (2) within-subject effect of BoNT-A and the effect of time since W0 as independent variables. Comprehensive treatment of PSS with BoNT-A significantly decreased PSS of the upper limb with a maximal effect at W4. Task-related fMRI prior to treatment (W0) showed extensive activation of bilateral frontoparietal sensorimotor cortical areas, bilateral cerebellum, and contralesional basal ganglia and thalamus. After BoNT-A application (W4), the activation extent decreased globally, mostly in the bilateral parietal cortices and cerebellum, but returned close to baseline at W11. The intra-subject contrast revealed a significant BoNT-A effect, manifesting as a transient decrease in the activation of the ipsilesional intraparietal sulcus and superior parietal lobule. We demonstrate that BoNT-A treatment of PSS of the upper limb is associated with transient changes in the ipsilesional posterior parietal cortex, possibly resulting from temporarily altered sensorimotor upper limb representations.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Hok, Pavel $u Department of Neurology, Palacký University and University Hospital, Olomouc, Czechia.
- 700 1_
- $a Otruba, Pavel $u Department of Neurology, Palacký University and University Hospital, Olomouc, Czechia.
- 700 1_
- $a Zapletalová, Jana $u Department of Biophysics, Biometry and Statistics, Palacký University and University Hospital, Olomouc, Czechia.
- 700 1_
- $a Kukolová, Barbora $u Rehabilitation Centre, Hrabyně, Czechia.
- 700 1_
- $a Tüdös, Zbyněk $u Department of Radiology, Palacký University and University Hospital, Olomouc, Czechia.
- 700 1_
- $a Krobot, Alois $u Department of Physiotherapy, Palacký University and University Hospital, Olomouc, Czechia.
- 700 1_
- $a Kaňovský, Petr $u Department of Neurology, Palacký University and University Hospital, Olomouc, Czechia.
- 700 1_
- $a Hluštík, Petr $u Department of Neurology, Palacký University and University Hospital, Olomouc, Czechia. Department of Radiology, Palacký University and University Hospital, Olomouc, Czechia.
- 773 0_
- $w MED00174552 $t Frontiers in neurology $x 1664-2295 $g Roč. 10, č. - (2019), s. 495
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31143157 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20190819104200 $b ABA008
- 999 __
- $a ind $b bmc $g 1434101 $s 1067412
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 10 $c - $d 495 $e 20190509 $i 1664-2295 $m Frontiers in neurology $n Front. neurol. $x MED00174552
- LZP __
- $a Pubmed-20190813